apalutamide,abiraterone
janssen
[' apa ', 'presto']
presto: ph 3 rct of androgen annihilation in high-risk bcr after rp 52 wks rx bpfs: med 24.9 mos adt + apa vs 20.3 mos adt (hr 0.52, 95% ci 0.35 0.77) bpfs: med 26.0 mos adt + apa + aap vs 20.0 mos adt (hr 0.48, 95% ci 0.32 0.71) no added benefit to aap #esmo22 
Uro Onc @GACancerCenter | Res PD & Ronald W. Lewis MD Chair of Uro Educ @mcg_urology | Digital Media Ed @EUplatinum | #mentalhealth research | @urotoday